Predicting cancer: can we? Should we?

More interesting, perhaps, from a clinical point of view, was the level of involvement of the audience and the clear fascination around such questions as personalised medicine ("How can this be," asked one audience member, "if all our tumours are different?") and what will happen...

Full description

Saved in:
Bibliographic Details
Published in:The lancet oncology 2016-11, Vol.17 (11), p.1494-1494
Main Author: Coburn, Cassandra
Format: Article
Language:English
Subjects:
Audiences
Biology
Biomarkers, Tumor - genetics
Cancer
Genetic Predisposition to Disease
Hematology, Oncology and Palliative Medicine
Humans
Molecular Diagnostic Techniques
Neoplasms - diagnosis
Neoplasms - genetics
Neoplasms - pathology
Phenotype
Predictive Value of Tests
Prognosis
Risk Assessment
Risk Factors
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:More interesting, perhaps, from a clinical point of view, was the level of involvement of the audience and the clear fascination around such questions as personalised medicine ("How can this be," asked one audience member, "if all our tumours are different?") and what will happen when over-the-counter testing becomes the norm (consensus: informed consent gets more complex and interesting).
ISSN:1470-2045
1474-5488
DOI:10.1016/S1470-2045(16)30523-X